Hamburg, Germany · Startup1KOMMA5° (named for the 1.5°C climate target) is one of Europe’s fastest-scaling energy transition companies, reaching unicorn status in roughly 21 months. Based in Hamburg, the firm tackles the “last mile” of decarbonization by combining a roll-up acquisition strategy with a software-defined energy platform. Instead of only selling solar panels, 1KOMMA5° acquires local installer businesses across Europe and digitizes them to deliver end-to-end home electrification — solar, batteries, heat pumps, and EV chargers — with consistent quality and financing. The company’s differentiator is Heartbeat, a proprietary energy management system that turns these assets into a virtual power plant. Heartbeat orchestrates when batteries charge or discharge based on real-time spot prices and grid conditions, allowing households to capture savings from dynamic tariffs and to export power during peak demand. In 2025, the system expanded to automated trading of household energy, making “free” electricity periods during windy or sunny hours a tangible consumer benefit. This blending of hardware deployment and energy-software automation allows 1KOMMA5° to capture margin both on installation and on recurring software and energy services. Founder Philipp Schroder (former Tesla country director and Sonnen executive) used his industry network to skip early accelerators, and the company instead embedded itself in the Hamburg Startup City ecosystem. Its acquisition engine is relentless: by buying regional market leaders, it locks in the most scarce resource in the sector — skilled installers — while rapidly expanding geographic reach. By early 2026, 1KOMMA5° had expanded beyond DACH into the Nordics, Spain, and Australia, positioning itself for a cross-continental footprint ahead of a public listing. The company has signaled an IPO-readiness push, backed by record turnover reported for 2024 and an expansion into branded hardware components to increase margin and supply-chain resilience. Its investor base blends strategic and growth capital: Porsche Ventures provided early backing, G2VP brought Silicon Valley cleantech expertise, Eurazeo and eCapital added European growth capital, and Norrsken VC underscored the impact thesis. In 2026, 1KOMMA5° is a case study in how Europe can scale climate tech through operational execution rather than pure technology — a disciplined roll-up with a software heart that turns millions of households into coordinated energy assets.
StartupGrowthCleanTechEnergyIoT
Munich, Germany · StartupProxima Fusion is a deep-tech fusion energy company spun out from the Max Planck Institute for Plasma Physics in 2023. It is developing quasi-isodynamic stellarator systems designed for stable, commercial fusion power generation and is targeting a demonstrator pathway toward net-energy performance in the next decade.
StartupGrowthDeep TechCleanTechEnergyClimate Tech
Bratislava, Slovakia · StartupAgeVolt offers a digital ecosystem for EV charging that integrates with building energy management to prevent overloads and blackouts. Its platform optimizes charging schedules, manages access, and supports payments across fleets and commercial properties. The company is building a network model described as a “booking.com for private chargers,” unlocking underused charging infrastructure. By 2026, AgeVolt is a notable Slovak player in smart charging.
StartupGrowthEV ChargingEnergySoftware
Paris, France · StartupBioptimus is the self-proclaimed "Mistral of Biology," spun out in early 2024 by a team of alumni from Google DeepMind and Owkin, including CEO Jean-Philippe Vert. The company is building what it calls the first universal foundation model for biology. Where large language models were trained on text to learn human language, Bioptimus trains on biological data—DNA sequences, protein structures, cellular imagery, and clinical phenotypes—to infer the underlying rules of life. The ambition is not just better predictions but a unified biological reasoning layer that can simulate outcomes before expensive lab work happens.
By 2026, Bioptimus has moved from a research thesis to early commercial traction. After a $41M Series A in 2025, the company released its first commercial model that can predict how a specific molecule will interact with a human cell with unusually high accuracy. This enables in-silico screening that reduces wet-lab costs and improves hit rates for drug discovery. French pharma leaders such as Sanofi have begun using these models to prioritize compounds and compress early-stage discovery timelines. The product value is immediate: fewer failed experiments, faster candidate selection, and deeper mechanistic insight.
Bioptimus' roadmap focuses on "multi-scale biology," connecting the micro level (genomics and proteomics) to the macro level (patient outcomes and clinical data). Rather than being limited to protein folding, the models aim to bridge across data modalities so a genetic mutation can be linked to disease pathways, tissue behavior, and potential therapeutic interventions. This requires data breadth and regulatory trust, and Bioptimus is building a defensive moat through European data sovereignty. It leverages partnerships with European research hospitals and biobanks to access high-quality patient data that is difficult for US competitors to acquire under GDPR constraints. That compliance burden becomes a competitive advantage: safer access, better provenance, and stronger alignment with European health data governance.
The company remains deeply embedded in the Paris ecosystem. It was incubated inside Owkin before spinning out, maintains a presence around Station F, and benefits from the cross-pollination between French AI and biotech communities. Its investor base reflects that positioning: Sofinnova Partners, Bpifrance, Cathay Innovation, Xavier Niel, and Frst provide a blend of life-science expertise, sovereign capital, and deep-tech conviction. In 2026, Bioptimus is the clearest European bet that foundation models can unlock biology at scale—and a contender to become the default AI layer for drug discovery in Europe.
StartupGrowthBiotechAIHealthcare
Bratislava, Slovakia · StartupInoBat builds custom-designed batteries for demanding applications such as aviation, premium EVs, and performance mobility. Unlike standard gigafactory players, InoBat focuses on tailored R&D, pilot production, and high-value customers that require specialized chemistry and form factors. By 2026, the company is a strategic player in the EU battery value chain with backing from partners like Rio Tinto and Gotion High-Tech, positioning Slovakia as a serious contributor to Europe’s energy storage ecosystem.
StartupGrowthEnergyBatteriesManufacturing
Stockholm, Sweden · StartupNorthvolt is a Swedish battery manufacturer founded to build a European supply of sustainable lithium-ion cells. In November 2024, Northvolt AB filed for Chapter 11 protection in the United States to pursue a financial restructuring while seeking strategic solutions for Northvolt North America. On March 12, 2025, the company filed for bankruptcy in Sweden and a trustee was appointed to oversee the process. Northvolt remains a landmark industrial project for Europe’s battery ambitions, but its current status is restructuring and insolvency rather than a typical growth-stage startup.
StartupIndustrial Scale-upClimateIndustrialEnergy
Loading comments...